Pakistan
· Delayed Price · Currency is PKR Haleon Pakistan Company Description
Haleon Pakistan Limited engages in the research and development, manufacture, marketing, and sale of consumer healthcare products primarily in Pakistan.
The company offers products in the areas of pain relief under the Panadol brand; oral health under the Sensodyne and Parodontax brand names; respiratory health under the Panadol CF, Sancos, T-Day, Tandegyl, and Actified brands; nutrition and gastrointestinal health under the CaC-1000 PLUS, ENO, and QalSium-D brand names; and skin health under the Physiogel, Hydrozole, SunBlock 60, Lamisil, Acne Aid, Duofilm, SpectraBan, Brevoxyl, and Oilatum brands.
It also exports its products. The company was incorporated in 2015 and is headquartered in Karachi, Pakistan.
The company was formerly known as GlaxoSmithKline Consumer Healthcare Pakistan Limited and changed its name to Haleon Pakistan Limited in January 2023.
Haleon Pakistan Limited operates as a subsidiary of Glaxosmithkline Consumer Healthcare B.V.
| Country | Pakistan |
| Founded | 2015 |
| Industry | Pharmaceutical Preparations |
| Employees | 478 |
| CEO | Farhan Haroon |
Contact Details
Address: 11-A, Sky Tower (East Wing) Karachi, 75600 Pakistan | |
| Phone | 92 21 111 475 725 |
| Website | pk-consumerhealthcare.gsk.com |
Stock Details
| Ticker Symbol | HALEON |
| Exchange | Pakistan Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | PKR |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Farhan Haroon | Chief Executive Officer |
| Dilawar Meghani | Chief Financial Officer |